CoinVoice has recently learned that, according to the latest market information, MEI Pharma (NASDAQ: MEIP) has risen over 33% today, with a market capitalization increasing to $41.2431 million. Previously, it was learned that Titan Partners Group and the cryptocurrency investment firm GSR are jointly leading a strategic transformation of the American pharmaceutical company MEI Pharma (NASDAQ: MEIP), promoting the establishment of a dedicated Litecoin treasury strategy. Currently, over $100 million in funding commitments have been made for this project. Litecoin founder Charlie Lee has agreed to join the board of MEI Pharma. [Original link]